KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNA10 | Potassium voltage-gated channel, shaker-related subfamily, member 10 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNA3 | Potassium voltage-gated channel, shaker-related subfamily, member 3 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNA4 | Potassium voltage-gated channel, shaker-related subfamily, member 4 | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNA6 | Potassium voltage-gated channel, shaker-related subfamily, member 6 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNA7 | Potassium voltage-gated channel, shaker-related subfamily, member 7 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNB2 | Potassium voltage-gated channel, Shab-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNC3 | Potassium voltage-gated channel, Shaw-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNC4 | Potassium voltage-gated channel, Shaw-related subfamily, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Mixed |
KCND1 | Potassium voltage-gated channel, Shal-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Mixed |
KCND2 | Potassium voltage-gated channel, Shal-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCND3 | Potassium voltage-gated channel, Shal-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNG2 | Potassium voltage-gated channel, subfamily G, member 2 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
KCNG3 | Potassium voltage-gated channel, subfamily G, member 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNG4 | Potassium voltage-gated channel, subfamily G, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNH2 | Potassium voltage-gated channel, subfamily H (eag-related), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH3 | Potassium voltage-gated channel, subfamily H (eag-related), member 3 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH4 | Potassium voltage-gated channel, subfamily H (eag-related), member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
KCNH5 | Potassium voltage-gated channel, subfamily H (eag-related), member 5 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH7 | Potassium voltage-gated channel, subfamily H (eag-related), member 7 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNH8 | Potassium voltage-gated channel, subfamily H (eag-related), member 8 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNQ3 | Potassium voltage-gated channel, KQT-like subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNQ4 | Potassium voltage-gated channel, KQT-like subfamily, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS2 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNV1 | Potassium channel, subfamily V, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNV2 | Potassium channel, subfamily V, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |